Insufficient scRNA-seq data for expression of CEBPE at single-cell level.
Insufficient scRNA-seq data for expression of CEBPE at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 97% | 42.59 | 561 / 578 | 9% | 0.34 | 103 / 1155 |
| spleen | 100% | 236.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 87% | 651.91 | 805 / 929 | 0% | 0 | 0 / 0 |
| muscle | 81% | 13.49 | 653 / 803 | 0% | 0 | 0 / 0 |
| intestine | 63% | 12.67 | 612 / 966 | 15% | 0.36 | 81 / 527 |
| heart | 77% | 8.52 | 659 / 861 | 0% | 0 | 0 / 0 |
| adipose | 71% | 9.79 | 851 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 63% | 5.03 | 56 / 89 | 3% | 0.05 | 29 / 901 |
| brain | 56% | 5.15 | 1481 / 2642 | 10% | 0.15 | 70 / 705 |
| uterus | 48% | 3.45 | 82 / 170 | 13% | 0.83 | 59 / 459 |
| blood vessel | 58% | 6.18 | 769 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 47% | 3.69 | 309 / 653 | 9% | 0.14 | 54 / 605 |
| stomach | 43% | 3.80 | 155 / 359 | 11% | 0.22 | 31 / 286 |
| adrenal gland | 51% | 3.59 | 131 / 258 | 1% | 0.02 | 3 / 230 |
| breast | 48% | 3.88 | 219 / 459 | 3% | 0.04 | 34 / 1118 |
| bladder | 33% | 3.19 | 7 / 21 | 15% | 0.34 | 74 / 504 |
| prostate | 48% | 3.54 | 117 / 245 | 0% | 0 | 0 / 502 |
| liver | 42% | 5.31 | 94 / 226 | 1% | 0.02 | 3 / 406 |
| esophagus | 38% | 2.73 | 550 / 1445 | 3% | 0.04 | 5 / 183 |
| ovary | 37% | 2.69 | 67 / 180 | 0% | 0.00 | 1 / 430 |
| pancreas | 23% | 1.98 | 77 / 328 | 11% | 0.20 | 19 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 0.95 | 9 / 29 |
| skin | 24% | 1.52 | 427 / 1809 | 4% | 0.08 | 21 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.19 | 5 / 45 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030225 | Biological process | macrophage differentiation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0006351 | Biological process | DNA-templated transcription |
| GO_0030851 | Biological process | granulocyte differentiation |
| GO_0030099 | Biological process | myeloid cell differentiation |
| GO_0006909 | Biological process | phagocytosis |
| GO_0071222 | Biological process | cellular response to lipopolysaccharide |
| GO_0140467 | Biological process | integrated stress response signaling |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006952 | Biological process | defense response |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0044877 | Molecular function | protein-containing complex binding |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CEBPE |
| Protein name | CCAAT/enhancer-binding protein epsilon (C/EBP epsilon) |
| Synonyms | |
| Description | FUNCTION: Transcriptional activator . C/EBP are DNA-binding proteins that recognize two different motifs: the CCAAT homology common to many promoters and the enhanced core homology common to many enhancers. Required for the promyelocyte-myelocyte transition in myeloid differentiation . . |
| Accessions | ENST00000206513.6 Q15744 |